Related Experiment Video
Updated: Jan 15, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Genetic Basis of Hypsarrhythmia: Expanding the PHACTR1 Spectrum and Pathway to Targeted Therapy
Karen Willième1, Annelies Dheedene2, Arnaud Vanlander1
1Department of Paediatrics, Division Paediatric Neurology, Ghent University Hospital, Ghent, Belgium.
Insights
A novel PHACTR1 gene variant was identified in an infant with infantile spasms and hypsarrhythmia. This finding highlights a potential therapeutic target involving the PHACTR1 and Slack channel pathway for epilepsy treatment.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Infantile spasms and hypsarrhythmia are severe epilepsy syndromes in infants.
- The PHACTR1 gene encodes a protein involved in cytoskeletal regulation and signaling.
- Slack (KCNT1) channels are sodium-activated potassium channels implicated in various epilepsy types.
Abstract:
We report a 5-month-old girl with a novel PHACTR1 variant, presenting with infantile spasms and hypsarrhythmia. PHACTR1 encodes a protein with a unique actin- and phosphatase-binding structure, interacting with Slack (KCNT1-encoded), a Na+-activated K+-channel linked to epilepsy. This shared pathway may offer a promising avenue to future therapy.
More Related Videos
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Electrophysiology of Normal Cardiac Rhythm
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

